Cargando…

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The outcome of adaptation is often referred to as ‘physical dependence’ in pharmacology, as distinct from addiction, although these terms have unfortunately become conflated in some diagnostic guides. Physical depend...

Descripción completa

Detalles Bibliográficos
Autores principales: Horowitz, Mark Abie, Framer, Adele, Hengartner, Michael P., Sørensen, Anders, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911477/
https://www.ncbi.nlm.nih.gov/pubmed/36513909
http://dx.doi.org/10.1007/s40263-022-00960-y
_version_ 1784884998054084608
author Horowitz, Mark Abie
Framer, Adele
Hengartner, Michael P.
Sørensen, Anders
Taylor, David
author_facet Horowitz, Mark Abie
Framer, Adele
Hengartner, Michael P.
Sørensen, Anders
Taylor, David
author_sort Horowitz, Mark Abie
collection PubMed
description Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The outcome of adaptation is often referred to as ‘physical dependence’ in pharmacology, as distinct from addiction, although these terms have unfortunately become conflated in some diagnostic guides. Physical dependence to antidepressants may occur in some patients, consistent with the fact that some patients experience withdrawal effects from these medications. It is thought that longer duration of use, higher dose and specific antidepressants affect the risk of antidepressant withdrawal effects as they might cause greater adaptation of the brain. We searched PubMed for relevant systematic reviews and other relevant analyses to summarise existing data on determinants of antidepressant withdrawal incidence, severity and duration. Overall, data were limited. From survey data, increased duration of use was associated with an increased incidence and severity of withdrawal effects, consistent with some evidence from data provided by drug manufacturers. Duration of use may be related to duration of withdrawal effects but data are heterogenous and sparse. Serotonin and noradrenaline reuptake inhibitors and paroxetine are associated with higher risks than other antidepressants, though data for some antidepressants are lacking. Higher doses of antidepressant has some weak association with an increased risk of withdrawal, with some ceiling effects, perhaps reflecting receptor occupancy relationships. Past experience of withdrawal effects is known to predict future risk. Based on these data, we outline a preliminary rubric for determining the risk of withdrawal symptoms for a particular patient, which may have relevance for determining tapering rates. Given the limited scope of the current research, future research should aim to clarify prediction of antidepressant withdrawal risk, especially by examining the risk of withdrawal in long-term users of medication, as well as the severity and duration of effects, to improve the preliminary tool for predictive purposes. Further research into the precise adaptations in long-term antidepressant use may improve the ability to predict withdrawal effects for a particular patient.
format Online
Article
Text
id pubmed-9911477
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99114772023-02-11 Estimating Risk of Antidepressant Withdrawal from a Review of Published Data Horowitz, Mark Abie Framer, Adele Hengartner, Michael P. Sørensen, Anders Taylor, David CNS Drugs Review Article Adaptation of the brain to the presence of a drug predicts withdrawal on cessation. The outcome of adaptation is often referred to as ‘physical dependence’ in pharmacology, as distinct from addiction, although these terms have unfortunately become conflated in some diagnostic guides. Physical dependence to antidepressants may occur in some patients, consistent with the fact that some patients experience withdrawal effects from these medications. It is thought that longer duration of use, higher dose and specific antidepressants affect the risk of antidepressant withdrawal effects as they might cause greater adaptation of the brain. We searched PubMed for relevant systematic reviews and other relevant analyses to summarise existing data on determinants of antidepressant withdrawal incidence, severity and duration. Overall, data were limited. From survey data, increased duration of use was associated with an increased incidence and severity of withdrawal effects, consistent with some evidence from data provided by drug manufacturers. Duration of use may be related to duration of withdrawal effects but data are heterogenous and sparse. Serotonin and noradrenaline reuptake inhibitors and paroxetine are associated with higher risks than other antidepressants, though data for some antidepressants are lacking. Higher doses of antidepressant has some weak association with an increased risk of withdrawal, with some ceiling effects, perhaps reflecting receptor occupancy relationships. Past experience of withdrawal effects is known to predict future risk. Based on these data, we outline a preliminary rubric for determining the risk of withdrawal symptoms for a particular patient, which may have relevance for determining tapering rates. Given the limited scope of the current research, future research should aim to clarify prediction of antidepressant withdrawal risk, especially by examining the risk of withdrawal in long-term users of medication, as well as the severity and duration of effects, to improve the preliminary tool for predictive purposes. Further research into the precise adaptations in long-term antidepressant use may improve the ability to predict withdrawal effects for a particular patient. Springer International Publishing 2022-12-14 2023 /pmc/articles/PMC9911477/ /pubmed/36513909 http://dx.doi.org/10.1007/s40263-022-00960-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review Article
Horowitz, Mark Abie
Framer, Adele
Hengartner, Michael P.
Sørensen, Anders
Taylor, David
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title_full Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title_fullStr Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title_full_unstemmed Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title_short Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
title_sort estimating risk of antidepressant withdrawal from a review of published data
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911477/
https://www.ncbi.nlm.nih.gov/pubmed/36513909
http://dx.doi.org/10.1007/s40263-022-00960-y
work_keys_str_mv AT horowitzmarkabie estimatingriskofantidepressantwithdrawalfromareviewofpublisheddata
AT frameradele estimatingriskofantidepressantwithdrawalfromareviewofpublisheddata
AT hengartnermichaelp estimatingriskofantidepressantwithdrawalfromareviewofpublisheddata
AT sørensenanders estimatingriskofantidepressantwithdrawalfromareviewofpublisheddata
AT taylordavid estimatingriskofantidepressantwithdrawalfromareviewofpublisheddata